Organigram Global Inc. (OGI) vs Sofgen Pharma S.A (PROCF)
- Organigram Global Inc. OGI 0.93 0.00%
- Sofgen Pharma S.A PROCF 0.03 0.00%
Organigram Global Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $131.4M against $114.0M — 1.2× the size. Sofgen Pharma S.A trades at the lower P/E: 0.1× against 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 5.10%. Organigram Global Inc. has the higher net margin (28.4% vs 9.52%) and the lower return on invested capital (−1.53% vs 15.2%). Across the 19 metrics below, Sofgen Pharma S.A leads on 10 and Organigram Global Inc. on 9.
Valuation
Profitability
| Metric | OGI | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 36.47% | 56.16% | 53.94% |
| Operating margin | (3.91%) | 17.01% | 0.00% |
| Net margin | 28.44% | 9.52% | 0.00% |
| Free cash flow margin | (9.46%) | 17.66% | 0.00% |
| Return on equity | 20.20% | (213.06%) | (0.40%) |
| Return on assets | 12.70% | 8.82% | (3.32%) |
| Return on invested capital | (1.53%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack